Skip to main content

Table 1 MIC of antibacterials in combination with mepyramine for E. coli ATCC® 25922™ and E. coli PIG 01

From: Histamine H1 receptor antagonists enhance the efficacy of antibacterials against Escherichia coli

Combination with MEP

MIC (μg/ml)

DRI

Median

DRI

Range

Alone

Combined

Median

Range

Median

Range

E. coli ATCC® 25922™

 AMX

1.5

1.5–2

1*

1.0–1.5

1.5

1.3–1.5

 SDZ/TMP

2

1–4

1**

0.3–1

3

2–8

 TET

0.5

0.5–0.5

0.3*

0.3–0.5

2

1–2

 CST

8

8–8

1**

1–2

8

4–8

 ENR

0.01

0.01–0.01

0.005**

0.005–0.005

2

2–2

 FFC

8

8–16

2**

2–4

4

4–4

 GEN

0.3

0.3–0.5

0.3

0.3–0.5

1

1–1

 KA

4

4.0–0.5

4

0.5–0.5

1

1–1

E. coli PIG 01

 AMX

1.5

1–3

1.3

0.8–2

1.5

1–1.5

 SDZ/TMP

2

2–4

2

1–2

1.5

1–2

 TET

1

1–4

0.5*

0.5–1

2

2–4

 CST

2

2–4

1.5

1–2

2

1–4

 ENR

16

16–16

8

8–16

2

1–2

 FFC

8

8–32

2**

2–4

4

4–8

 GEN

0.5

4–4

0.5

4–4

1

1–1

 KAN

8

4–8

8

4–8

1

1–1

  1. Data are expressed as median and range (n = 6)
  2. Statistical significances were assessed between MIC alone and combined
  3. AMX Amoxicillin, SDZ/TMP Sulfadiazine/trimethoprim, TET Tetracycline, CST Colistin, ENR Enrofloxacin, FFC Florfenicol, GEN Gentamicin, KAN Kanamycin, MEP Mepyramine, MIC Minimum inhibitory concentration, DRI Dose reduction index (MICalone / MICcombined)
  4. *Significantly different (p < 0.05), **Significantly different (p < 0.01)